AI assistant
Sending…
Immunovia — Major Shareholding Notification 2020
Jun 5, 2020
3061_iss_2020-06-05_a1a34510-ac47-4c06-99c4-cc8d4adf7937.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Immunovia AB (publ)
Holder
Swedbank Robur fonder AB
Instrument
| Instrument | Aktier SE0006091997 | |
|---|---|---|
| Before the transaction | ||
| Shares | 555,000 | |
| Voting rights | 555,000 | |
| Transaction | ||
| Reason for major shareholding notification New share issue | ||
| Date | 04/06/2020 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 1,405,000 | |
| Directly held voting rights | 1,405,000 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 6.22 % | |
| Directly held voting rights | 6.22 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||
|---|---|---|---|
| Shares | 6.22 % | 1,405,000 | |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
|||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
|||
| - Physically settled | |||
| - Cash settled | |||
| Total | 6.22 % | 1,405,000 | |
| Notes (other relevant informations according to law) Flaggningen är beräknad på 22 603 081 utestående aktier. |
Published
05/06/2020 11:28
Contact
Name Mia Metso Ekberg
Phone 08-58597525 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Immunovia
Major Shareholding Notification
2026
Jun 2
Major Shareholding Notification
2026
May 22
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Interim / Quarterly Report
2026
May 7
Interim / Quarterly Report
2026
May 7
Major Shareholding Notification
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 13
Proxy Solicitation & Information Statement
2026
Apr 13
Interim / Quarterly Report
2026
Feb 24